Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomasQing Deng, Michael R. Green, Neeraj Jain et al.|Nature Medicine|2020Cited by 593
SMARCA4 is a haploinsufficient B cell lymphoma tumor suppressor that fine-tunes centrocyte cell fate decisionsQing Deng, Michael R. Green|Cancer Cell|2024Cited by 28
Large B cell lymphoma microenvironment archetype profilesXubin Li, Michael R. Green, Kartik Singhal et al.|Cancer Cell|2025Cited by 21
A national risk analysis model (NRAM) for the assessment of COVID‐19 epidemicQing Deng, Yi Liu, Xingyu Xiao et al.|Risk Analysis|2023Cited by 4